je.st
news
Tag: risk
How Do You Buffer Your Operation Against External Risk?
2014-01-02 18:51:48| Beef
This week’s online poll question is “What’s your primary means of buffering your business against external risk?” Be sure to leave your thoughts in the comments section after voting. Increasing working capital Managing costs Paying down/restructuring debt Locking in margins
Tags: operation
risk
external
buffer
2013 World-Wide Credit Risk Winners And Losers
2014-01-01 11:26:13| Grocery - Topix.net
Which corporations had the biggest decreases and biggest increases in credit risk in 2013? The biggest decreases in credit risk in 2013 came from Sharp , Yellow Media Ltd. , Axtel S.A.B. de C.V. of Mexico, A2A S.p.A of Italy, and Supervalu Inc. .
Tags: credit
risk
worldwide
winners
Campbell Recalls 300 Cases of Prego Traditional Italian Sauce Due to a Risk of Spoilage
2014-01-01 04:03:31| Food - Topix.net
FOR IMMEDIATE RELEASE December 31, 2013 Campbell Soup Company is voluntarily recalling approximately 300 cases of 24-ounce jars of Prego Traditional Italian sauce because of a risk of spoilage.
Tags: of
due
cases
traditional
Extreme Weather Puts UKs Hedgehog Population at Risk
2013-12-30 20:48:00| Climate Ark Climate Change & Global Warming Newsfeed
EcoWatch: The hedgehog population has fallen by 25 percent in the past decade in England due to intensive farming in the countryside and, in the suburbs, more and more cars and paved-over spaces. This years hedgehogs face another threat as many were born late, due to a wet summer and a warm October and may not have enough body fat to survive hibernation. Baby hedgehogs begin to leave their nests at the tender age of five to six weeks old. Those that are born later in the season simply arent able to consume...
Tags: risk
weather
extreme
population
FDA Accepts For Review ELIQUIS (apixaban) Supplemental New Drug Application For The Treatment Of Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE), And For The Reduction In The Risk Of Recurrent DVT And PE
2013-12-30 05:21:47| drugdiscoveryonline News Articles
Bristol-Myers Squibb Company and Pfizer Inc. recently announced that the U.S. Food and Drug Administration (FDA) has accepted for review a Supplemental New Drug Application (sNDA) for ELIQUIS (apixaban) for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and for the reduction in the risk of recurrent DVT and PE
Sites : [390] [391] [392] [393] [394] [395] [396] [397] [398] [399] [400] [401] [402] [403] [404] [405] [406] [407] [408] [409] next »